Secondaries

Unlock the Value of Non-Core Assets

In today’s dynamic economic climate, the strategic divestment of non-core assets has become an invaluable tool for both private and institutional investors. This approach allows for portfolio optimisation and a focus on exit and disinvestment strategies tailored to current market conditions.

The process of exiting non-strategic equity interests can be time-consuming and complex, often diverting internal financial management resources from core activities. BRESLIN has an experienced investment team to streamline the placement and divestment process, enabling your internal teams to concentrate on essential management tasks.

As a European pioneer and leading authority in exit management and externalisation of investments, BRESLIN specialises in the divestment of company stakes, fund portfolios, and private equity project developments. We are also recognised globally for our expertise in “early-stage assets.” Over the years, BRESLIN has successfully executed transactions for renowned global corporations, banks, and institutional investors such as UBS, Bayer, Henkel and Novartis as well as family offices and high-net-worth investors seeking to exit their investments in private companies or funds.

BRESLIN has developed and refined a suite of tools to ensure the successful management of transactions with full discretion and confidentiality. Our comprehensive services include portfolio validation and adaptation to market needs, deal structuring, asset auctioning to strategic and financial buyers, negotiation of terms, legal support, execution, and coordination of all transaction aspects. We are committed to employing strategies that maximise the commercial potential of our clients’ transactions, particularly through globally executed structured auctions.

Our experienced private equity team, with a transaction volume exceeding $1.5 billion, is ready to provide detailed insights into the secondary market and the specific mechanisms and procedures of asset transfers. We offer advisory and support services tailored to your strategy and needs, with no obligation to sell assets.

Achievements in Secondaries

Years in Sector

0

Successful transactions closed

0

Investors and strategic industrial partners

0

Life science transactions closed

$ 0 Mio

Closed deals in Private Equity, Finance and Science Sectors

$ 0 billion

Breslin AG
Gubelstrasse 19, 8050, Zürich, Switzerland